AI drug discovery

Irving, Texas, USA, September 2, 2026 Caris Life Sciences will present new research highlighting advances in precision oncology, molecular...

Hong Kong, September 1, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), has announced...

HONG KONG, Aug 27, 2026 Akeso, Inc. announced its 2026 interim results, reporting record commercial drug sales while advancing...

SHANGHAI, China, August 21, 2026 Dizal Pharmaceutical announced that emerging clinical data for ZEGFROVY® (sunvozertinib) will be presented at...

NANJING, China, August 21, 2026 Nanjing Leads Biolabs Co., Ltd. announced that China’s Center for Drug Evaluation (CDE) under...

San Francisco, California, August 20, 2026 Chai Discovery has announced a collaboration with Bristol Myers Squibb (BMS) to advance...

BOULDER, Colo., August 18, 2026 Enveda announced positive Phase 1 results for ENV-308, an investigational oral medicine designed from...

Chicago, Illinois, August 18, 2026 VectorBuilder and Lir Therapeutics have announced a strategic collaboration to advance adeno-associated virus (AAV)...

Hong Kong, August 14, 2026 Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), has...

Tokyo, Japan, August 5, 2026 Kirin Holdings Co., Ltd. and GenerativeX Inc. have launched a new research model that...